Earth-friendly-assessed UV-spectrophotometric approaches for concurrent determination of mirabegron and solifenacin succinate in different matrices

Sustainable Chemistry and Pharmacy - Tập 32 - Trang 100976 - 2023
Rania A. Sayed1, Ahmed R. Mohamed2, Abdalla Shalaby1, Hany Ibrahim2
1Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt
2Analytical Chemistry Department, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo, 11829, Egypt

Tài liệu tham khảo

Abrams, 2015, Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony), Eur. Urol., 67, 577, 10.1016/j.eururo.2014.02.012 Banakhar, 2012, Pathophysiology of overactive bladder, Int. Urogynecol. J., 23, 975, 10.1007/s00192-012-1682-6 Brading, 1997, A myogenic basis for the overactive bladder, Urology, 50, 57, 10.1016/S0090-4295(97)00591-8 Drake, 2014, Do we need a new definition of the overactive bladder syndrome? ICI‐RS 2013, Neurourol. Urodyn., 33, 622, 10.1002/nau.22609 Elmasry, 2021, Simple mathematical data processing method for the determination of sever overlapped spectra of linagliptin and empagliflozin in their pure forms and pharmaceutical formulation: Fourier self deconvulated method, Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 254, 10.1016/j.saa.2021.119609 Elmasry, 2022, Spectrophotometric determination of aspirin and omeprazole in the presence of salicylic acid as a degradation product: a comparative evaluation of different univariate/multivariate post processing algorithms, J. AOAC Int., 105, 309, 10.1093/jaoacint/qsab105 Eltink, 2012, Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, Int. J. Clin. Pharm. Ther., 50, 838, 10.5414/CP201782 Fawzy, 2022, Different approaches for the assessment of greenness of spectrophotometric methodologies utilized for resolving the spectral overlap of newly approved binary hypoglycemic pharmaceutical mixture, Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 272, 10.1016/j.saa.2022.120998 Goodman, 2011, 237 Gratzke, 2018, Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: a randomised, multicentre phase 3 study (SYNERGY II), Eur. Urol., 74, 501, 10.1016/j.eururo.2018.05.005 Ibrahim, 2022, Simultaneous analysis of two drugs used as supportive treatment for COVID-19: comparative statistical studies and analytical ecological appraisal, BMC Chem., 16, 1, 10.1186/s13065-022-00860-8 2005, Validation of analytical procedures: text and methodology Iitsuka, 2015, Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy East Asian subjects, Clin. Therapeut., 37, 1031, 10.1016/j.clinthera.2015.02.021 Krauwinkel, 2005, Effect of age on the pharmacokinetics of solifenacin in men and women, Int. J. Clin. Pharm. Ther., 43, 227, 10.5414/CPP43227 Maniscalco, 2006, Solifenacin succinate for the treatment of symptoms of overactive bladder, Clin. Therapeut., 28, 1247, 10.1016/j.clinthera.2006.09.017 Mohamed, 2022, Utility of silver-nanoparticles for nano-fluorimetric determination of vancomycin hydrochloride in pharmaceutical formulation and biological fluids: greenness assessment, J. Fluoresc., 32, 1899, 10.1007/s10895-022-02942-1 Mohamed, 2022, Innovative earth-friendly UV-spectrophotometric technique for in-vitro dissolution testing of miconazole nitrate and nystatin in their vaginal suppositories: greenness assessment, J. AOAC Int., 105, 1528, 10.1093/jaoacint/qsac074 Patel, 2022, Development and validation of UV and RP-HPLC methods for simultaneous estimation of mirabegron and solifenacin succinate in their pharmaceutical dosage form, Int. J. Pharm. Biol. Med. Sci., 2, 223 Robinson, 2018, Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients, Neurourol. Urodyn., 37, 394, 10.1002/nau.23315 Sayed, 2021, Comparative study of novel green UV-spectrophotometric platforms for simultaneous rapid analysis of flumethasone pivalate and clioquinol in their combined formulation, Drug Dev. Ind. Pharm., 47, 867, 10.1080/03639045.2021.1908341 Sayed, 2021, Smart UV-spectrophotometric platforms for rapid green analysis of miconazole nitrate and nystatin in their combined suppositories and in vitro dissolution testing, Drug Dev. Ind. Pharm., 47, 1469, 10.1080/03639045.2021.2001490 Shah, 2019, High-Performance Thin-Layer chromatographic method for the estimation of mirabegron and solifenacin succinate used in the treatment of overactive bladder syndrome, JPC–J. Planar Chromatogr. TLC., 32, 323, 10.1556/1006.2019.32.4.7 Warren, 2016, Mirabegron in overactive bladder patients: efficacy review and update on drug safety, Ther. Adv. Drug Saf., 7, 204, 10.1177/2042098616659412 White, 2016, Overactive bladder, Obstet. Gynecol. Clin., 43, 59, 10.1016/j.ogc.2015.10.002 Zeid, 2022, Green microemulsion electrokinetic chromatographic method for simultaneous determination of azelastine and budesonide, Sustain. Chem. Pharm., 29